Caracot, Sharmie S.
HRN: 17-81-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 500MG (TAB)
06/05/2022
06/11/2022
ORAL
500mg
BID
S/P NSVD; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes